These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 14573645)

  • 1. Evaluation of Brucella abortus phosphoglucomutase (pgm) mutant as a new live rough-phenotype vaccine.
    Ugalde JE; Comerci DJ; Leguizamón MS; Ugalde RA
    Infect Immun; 2003 Nov; 71(11):6264-9. PubMed ID: 14573645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermediate rough Brucella abortus S19Δper mutant is DIVA enable, safe to pregnant guinea pigs and confers protection to mice.
    Lalsiamthara J; Gogia N; Goswami TK; Singh RK; Chaudhuri P
    Vaccine; 2015 May; 33(22):2577-83. PubMed ID: 25869887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brucella abortus 2308ΔNodVΔNodW double-mutant is highly attenuated and confers protection against wild-type challenge in BALB/c mice.
    Li Z; Wang S; Zhang J; Yang G; Yuan B; Huang J; Han J; Xi L; Xiao Y; Chen C; Zhang H
    Microb Pathog; 2017 May; 106():30-39. PubMed ID: 28131952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Brucella abortus O-polysaccharide and core lipopolysaccharide mutants and demonstration that a complete core is required for rough vaccines to be efficient against Brucella abortus and Brucella ovis in the mouse model.
    Monreal D; Grilló MJ; González D; Marín CM; De Miguel MJ; López-Goñi I; Blasco JM; Cloeckaert A; Moriyón I
    Infect Immun; 2003 Jun; 71(6):3261-71. PubMed ID: 12761107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
    Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
    Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.
    Grilló MJ; Manterola L; de Miguel MJ; Muñoz PM; Blasco JM; Moriyón I; López-Goñi I
    Vaccine; 2006 Apr; 24(15):2910-6. PubMed ID: 16439039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complementation of Brucella abortus RB51 with a functional wboA gene results in O-antigen synthesis and enhanced vaccine efficacy but no change in rough phenotype and attenuation.
    Vemulapalli R; He Y; Buccolo LS; Boyle SM; Sriranganathan N; Schurig GG
    Infect Immun; 2000 Jul; 68(7):3927-32. PubMed ID: 10858205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A potent Brucella abortus 2308 Δery live vaccine allows for the differentiation between natural and vaccinated infection.
    Zhang J; Yin S; Guo F; Meng R; Chen C; Zhang H; Li Z; Fu Q; Shi H; Hu S; Ni W; Li T; Zhang K
    J Microbiol; 2014 Aug; 52(8):681-8. PubMed ID: 24994009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Live Brucella abortus rough vaccine strain RB51 stimulates enhanced innate immune response in vitro compared to rough vaccine strain RB51SOD and virulent smooth strain 2308 in murine bone marrow-derived dendritic cells.
    Surendran N; Hiltbold EM; Heid B; Sriranganathan N; Boyle SM; Zimmerman KL; Makris MR; Witonsky SG
    Vet Microbiol; 2011 Jan; 147(1-2):75-82. PubMed ID: 20594772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of immune responses and resistance to brucellosis in mice vaccinated with Brucella abortus 19 or RB51.
    Stevens MG; Olsen SC; Pugh GW; Brees D
    Infect Immun; 1995 Jan; 63(1):264-70. PubMed ID: 7806364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo differences in the virulence, pathogenicity, and induced protective immunity of wboA mutants from genetically different parent Brucella spp.
    Wang Z; Niu J; Wang S; Lv Y; Wu Q
    Clin Vaccine Immunol; 2013 Feb; 20(2):174-80. PubMed ID: 23239800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brucella abortus S19 rfbD mutant is highly attenuated, DIVA enable and confers protection against virulent challenge in mice.
    Lalsiamthara J; Kaur G; Gogia N; Ali SA; Goswami TK; Chaudhuri P
    Biologicals; 2020 Jan; 63():62-67. PubMed ID: 31843357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of the Brucella abortus phosphoglucomutase gene: role of lipopolysaccharide in virulence and intracellular multiplication.
    Ugalde JE; Czibener C; Feldman MF; Ugalde RA
    Infect Immun; 2000 Oct; 68(10):5716-23. PubMed ID: 10992476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of immune responses in cattle vaccinated with Brucella abortus strain 19 or strain RB51.
    Stevens MG; Olsen SC; Cheville NF
    Vet Immunol Immunopathol; 1995 Feb; 44(3-4):223-35. PubMed ID: 7747403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Booster vaccination with safe, modified, live-attenuated mutants of Brucella abortus strain RB51 vaccine confers protective immunity against virulent strains of B. abortus and Brucella canis in BALB/c mice.
    Truong QL; Cho Y; Kim K; Park BK; Hahn TW
    Microbiology (Reading); 2015 Nov; 161(11):2137-48. PubMed ID: 26341622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant Ochrobactrum anthropi expressing Brucella abortus Cu,Zn superoxide dismutase protects mice against B. abortus infection only after switching of immune responses to Th1 type.
    He Y; Vemulapalli R; Schurig GG
    Infect Immun; 2002 May; 70(5):2535-43. PubMed ID: 11953393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant outer membrane protein 25c from Brucella abortus induces Th1 and Th2 mediated protection against Brucella abortus infection in mouse model.
    Paul S; Peddayelachagiri BV; Nagaraj S; Kingston JJ; Batra HV
    Mol Immunol; 2018 Jul; 99():9-18. PubMed ID: 29649688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune responses and resistance to brucellosis in mice vaccinated orally with Brucella abortus RB51.
    Stevens MG; Olsen SC; Palmer MV; Pugh GW
    Infect Immun; 1996 Nov; 64(11):4534-41. PubMed ID: 8890203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant bovine interleukin 2 enhances immunity and protection induced by Brucella abortus vaccines in cattle.
    Wyckoff JH; Howland JL; Scott CM; Smith RA; Confer AW
    Vet Microbiol; 2005 Nov; 111(1-2):77-87. PubMed ID: 16242273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Brucella melitensis M5-90 phosphoglucomutase (PGM) mutant is attenuated and confers protection against wild-type challenge in BALB/c mice.
    Zhang Y; Li T; Zhang J; Li Z; Zhang Y; Wang Z; Feng H; Wang Y; Chen C; Zhang H
    World J Microbiol Biotechnol; 2016 Apr; 32(4):58. PubMed ID: 26925620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.